Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2000 Oct 2;192(7):1015–1026. doi: 10.1084/jem.192.7.1015

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2000 The Rockefeller University Press

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

The antiapoptotic effect of HO-1 is dependent on HO enzymatic activity. (A) 2F-2B ECs were cotransfected with β-galactosidase plus pcDNA3, HO-1 (β-actin/HO-1), or bcl-2 expression vectors. Cells were either left untreated (Control) or treated with the inhibitor of HO enzymatic activity SnPPIX. CoPPIX, a protoporphyrin that does not inhibit HO enzymatic activity, was used as a control treatment. Gray bars represent ECs treated with Act.D and black bars represent ECs treated with TNF-α plus Act.D. Results shown are the mean ± SD from duplicate wells taken from one representative experiment out of three. (B) 2F-2B ECs were transfected with β-galactosidase plus pcDNA3 expression vectors. ECs were either left untreated (Control) or were treated with SnPPIX and CoPPIX as in A. The results shown are the mean ± SD from duplicate wells taken from one representative experiment out of three.